PO3
Director Trades
| Date | Director | Value |
|---|
Company News
Purifloh to commence air purification testing on airborne tuberculosis in Indian hospitals
Purification specialist Purifloh (ASX: PO3) has announced it will commence in-vivo testing of its free radical generator (FRG) technology at two hospitals in the Indian city of Hyderabad next month. The trials will be conducted via the company’s research partner Somnio Global, and will aim to demonstrate the efficacy of Purifloh’s FRG-based air purification system […]
Purifloh secures exclusive global license for free radical technology
Purification specialist Purifloh (ASX: PO3) has secured an exclusive global license for free radical generator technology developed by Somnio Global Holdings after converting a heads of agreement signed in December to a formal and binding licence agreement. Purifloh now holds the rights to FRG technology as it applies to the treatment of water and fluids, […]
Purifloh to develop Free Radical Generation technology through $9.6m equity raising
Purification specialist Purifloh (ASX: PO3) has completed a landmark $9.6 million equity raising with a key cornerstone investor in the United States to initiate commercial development opportunities for its Free Radical Generator (FRG) technology. The raising was achieved through the placement of 4 million Purifloh shares with Michigan-based Upjohn Laboratories, at a price of $2.40 […]
Company Videos
No videos found.